Granules India Ltd - Company Profile
Powered by 
All the sales intelligence you need on Granules India Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Granules India Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Granules India Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Granules India Ltd (Granules) develops, manufactures and sells Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFI) and Finished Dosages (FD).
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Granules is advancing its transformation into a leading R&D-driven organisation through the strategic expansion of its product development capabilities. Its R&D network includes four key centers: the Integrated Product Development R&D Center at Genome Valley, the Center of Excellence (CoE) at Pragathi Nagar focused on controlled substance APIs and KSMs, a bio lab at Pragathi Nagar specialising in enzyme and fermentation capabilities and the R&D Center at Genome Valley at Pune, Maharashtra. Additionally, its Formulation R&D Center at Granules Pharma Inc. (GPI), Virginia, USA, is dedicated to developing complex formulations. It is actively progressing with product pipelines in oncology, anti-diabetic drugs, large-volume molecules, and various dosage forms. The company consists of over 400 scientists all over India, the US and Switzerland advancing a focused pipeline in oncology, CNS/ ADHD and metabolic disorders. It has secured abbreviated new drug application (ANDA) approvals for several finished dosage forms, emphasising its commitment to innovation and regulatory compliance. In FY2025, the company invested INR2377 million in its R&D activities, which as a percentage of revenue stood at 5.3%.
Business Segments
- Active Pharmaceutical Ingredients (API)
- Finished Dosages (FD)
- Pharmaceutical Formulation Intermediates (PFI)
Overview
Focuses on the production and supply of APIs which include paracetamol, metformin, methocarbamol and guaifenesin among others. Serves customers through four APIs and intermediate facilities in Hyderabad and Visakhapatnam, with a combined installed capacity of 40,000 tonnes annually.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Focuses on vertically integrated dosage formulations, including the development of immediate-release, extended-release, delayed-release, and multi-particulate pellet system-based tablets and capsules. Also manufactures press fits, oral solutions, suspensions, and powders for oral solutions.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Includes manufacturing of caplets, tablets, and press-fit capsules available in bulk, blister packs, and bottles. Also manufactures bilayered tablets, rapid-release tablets, and extended-release (ER) tablets. Operates through its facilities present in Jeedimetla and Gagillapur. Six tonnes of batch processing capability.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer